Clinuvel Pharmaceuticals Limited

ASX:CUV Stock Report

Market Cap: AU$588.9m

Clinuvel Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

ASX:CUV Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Dec 24BuyAU$4,752,899JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany342,223AU$15.86
03 Dec 24SellAU$5,512,175JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany394,134AU$15.79
21 Aug 24BuyAU$15,812JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,171AU$13.58
21 Aug 24SellAU$1,945JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany144AU$13.51
20 Aug 24BuyAU$15,252JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,082AU$14.23
20 Aug 24SellAU$26,808JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,926AU$14.16
08 Aug 24BuyAU$19,370JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,411AU$13.77
08 Aug 24SellAU$10,101JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany728AU$13.99
06 Aug 24BuyAU$36,154JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany2,554AU$15.07
06 Aug 24SellAU$32,722JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany2,274AU$14.98
30 Jul 24BuyAU$4,677JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany318AU$14.84
30 Jul 24SellAU$5,329JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany362AU$14.98
26 Jul 24BuyAU$1,001,215JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany64,968AU$17.42
25 Jul 24SellAU$645,890JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany42,518AU$17.39
21 May 24BuyAU$49,796JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany3,292AU$15.35
20 May 24SellAU$108,527JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany7,181AU$15.43
09 May 24SellAU$617,496JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany40,983AU$15.42
08 May 24BuyAU$136,401JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany9,029AU$15.49
23 Apr 24BuyAU$79,703JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany5,304AU$15.81
23 Apr 24SellAU$865,136JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany56,759AU$15.90
04 Apr 24BuyAU$1,134,874JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany80,349AU$16.18
04 Apr 24SellAU$1,734,906JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany120,306AU$14.42
01 Mar 24BuyAU$2,751,897JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany200,309AU$14.18
01 Mar 24SellAU$2,836,865JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany203,327AU$14.32
23 Feb 24BuyAU$9,140,350JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany587,087AU$18.05
22 Feb 24SellAU$8,419,770JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany519,035AU$18.10

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CUV?
Owner TypeNumber of SharesOwnership Percentage
Public Companies152,1590.305%
Private Companies3,342,9936.69%
Individual Insiders5,195,64410.4%
Institutions12,193,99324.4%
General Public29,062,01158.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 41.02% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.6%
BNY Asset Management
4,296,471AU$50.7m11.5%0.01%
6.86%
Philippe Wolgen
3,425,222AU$40.4m0%no data
5.19%
Ender I , LLC
2,590,824AU$30.5m0%no data
4.81%
The Vanguard Group, Inc.
2,400,589AU$28.3m1.36%no data
3.14%
JPMorgan Chase & Co, Brokerage and Securities Investments
1,567,178AU$18.5m13.3%0.01%
2.03%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
1,014,469AU$12.0m9.85%no data
1.46%
Dimensional Fund Advisors LP
727,415AU$8.6m0.35%no data
1.2%
Emilino Group Pty Ltd
601,447AU$7.1m-0.33%no data
1.13%
BlackRock, Inc.
565,341AU$6.7m7.2%no data
0.87%
Norges Bank Investment Management
437,018AU$5.2m0%no data
0.73%
Darren Keamy
362,890AU$4.3m0%no data
0.69%
Mark Badcock
346,772AU$4.1m-21.2%no data
0.53%
AllianceBernstein L.P.
264,568AU$3.1m20.1%no data
0.46%
David Trevorrow
229,600AU$2.7m0%no data
0.46%
BNP Paribas Arbitrage Sa, Asset Management Arm
229,044AU$2.7m0%no data
0.38%
Dennis Wright
188,812AU$2.2m0%no data
0.37%
David Lewis
185,000AU$2.2m-1.07%no data
0.36%
Trent Redding
177,370AU$2.1m-1.18%no data
0.3%
Spheria Asset Management Pty Ltd
152,159AU$1.8m0%0.21%
0.3%
Spheria Emerging Companies Limited
152,159AU$1.8m0%no data
0.3%
Rusty Hammer Pty Ltd
150,722AU$1.8m-3.93%no data
0.29%
Simon Bown
146,000AU$1.7m0%no data
0.23%
Brenda Shanahan
116,577AU$1.4m0%no data
0.17%
Charles Schwab Investment Management, Inc.
82,777AU$975.9k0%no data
0.16%
Brenda Shanahan Charitable Foundation., Endowment Arm
80,000AU$943.2k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 22:17
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Clinuvel Pharmaceuticals Limited is covered by 10 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Thomas WakimBell Potter
Norbert KalliwodaDr. Kalliwoda Research
David StantonJefferies LLC